How do different European health authorities use comparative effectiveness research (CER) to determine drug coverage and pricing? A recent Health Affairs article by Cohen, Malins and Shahpurwala answer just this question. Here is a table summarizing the mission and priorities of health authorities in England, France, Germany and the Netherlands.
Source:
- Joshua Cohen, Ashley Malins, and Zainab Shahpurwala. Compared To US Practice, Evidence-Based Reviews In Europe Appear To Lead To Lower Prices For Some Drugs. 10.1377/hlthaff.2012.0707 HEALTH AFFAIRS 32, NO. 4 (2013)